Rapid differentiation of MOGAD and MS after a single optic neuritis
Authors
- T. Pakeerathan
- J. Havla
- C. Schwake
- A. Salmen
- M. Ringelstein
- O. Aktas
- M. Weise
- J.A. Gernert
- B. Kornek
- G. Bsteh
- A.K. Pröbstel
- A. Papadopoulou
- L. Kulsvehagen
- A.B. Ayroza Galvão Ribeiro Gomes
- N. Cerdá-Fuertes
- F.C. Oertel
- A.S. Duchow
- F. Paul
- J.P. Stellmann
- N. Stolowy
- K. Hellwig
- C. Schneider-Gold
- T. Kümpfel
- R. Gold
- P. Albrecht
- I. Ayzenberg
Journal
- Journal of Neurology
Citation
- J Neurol 271 (11): 7222-7231
Abstract
BACKGROUND: Optic neuritis (ON) is a common manifestation of multiple sclerosis (MS) and myelin-oligodendrocyte-glycoprotein IgG-associated disease (MOGAD). This study evaluated the applicability of optical coherence tomography (OCT) for differentiating between both diseases in two independent cohorts. METHODS: One hundred sixty two patients from seven sites underwent standard OCT and high-contrast visual acuity (HCVA) testing at least 6 months after first ON. Of these, 100 patients (32 MOGAD, 68 MS) comprised the primary investigational cohort, while 62 patients (31 MOGAD, 31 MS) formed a validation cohort. A composite score distinguishing between MOGAD and MS was developed using multivariate logistic regression. RESULTS: Bilateral simultaneous ON occurred more frequently in MOGAD compared to MS (46.9 vs. 11.8%, p < 0.001). OCT revealed more peripapillary retinal nerve fiber layer (pRNFL) atrophy in all segments in MOGAD compared to predominantly temporal pRNFL atrophy in MS (p < 0.001). HCVA was better preserved in MS (p = 0.007). pRNFL thickness in all except for temporal segments was suitable for differentiating MOGAD and MS. Simultaneous bilateral ON and critical atrophy in nasal (< 58.5 µm) and temporal superior (< 105.5 µm) segments were included into the composite score as three independent predictors for MOGAD. The composite score distinguished MOGAD from MS with 75% sensitivity and 90% specificity in the investigational cohort, and 68% sensitivity and 87% specificity in the validation cohort. CONCLUSION: Following a single ON-episode, MOGAD exhibits more pronounced global pRNFL atrophy and lower visual acuity after ON compared to MS. The introduced OCT-based composite score enabled differentiation between the two entities across both cohorts.